{
  "docId": "019de075-e061-72f9-baa2-90171b05eced",
  "docSlug": "cdaaa50efb264b4a4093f665bafb20a4",
  "documentTitle": "Absci | Investor Presentation Deck | 111 slides",
  "authorId": "absci",
  "authorName": "Absci",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 111,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses QR codes to link to specific research papers (Shanehsazzadeh et al. 2023, Constant et al. 2023, Bachas et al. 2022).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/11",
  "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced",
  "deckJsonHref": "/decks/019de075-e061-72f9-baa2-90171b05eced.json",
  "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.3,
        "w": 0.4,
        "x": 0.05,
        "y": 0.65
      },
      "kind": "image",
      "text": "Visual representation of research papers",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fb0b2018-c762-49db-a954-2f3a09370586",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.45,
        "x": 0.53,
        "y": 0.05
      },
      "kind": "list",
      "text": "March 2023: Designed and validated novel antibodies by CDRs design using zero-shot generative AI.",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "31d85089-2d5a-4dec-87ba-f6de2646408d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.45,
        "x": 0.53,
        "y": 0.65
      },
      "kind": "list",
      "text": "Aug 2022: Used artificial intelligence to simultaneously optimize multiple parameters important to drug discovery.",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4b77390a-b1eb-4925-b7a8-04cb13a8c373",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.45,
        "x": 0.53,
        "y": 0.35
      },
      "kind": "list",
      "text": "Feb 2023: Solved longstanding codon optimization problem and created largest expression database.",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "658a105e-3e1f-4198-8126-2e3fc60dd71c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.45,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Absci is the first to design and validate novel antibodies using zero-shot generative AI",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6e495589-f79e-4668-94cc-3c216dde87fd",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "608c5a94-61bc-4031-bf57-4220fb06ad6e",
      "evidence": "Chronological presentation of research milestones",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 12,
      "from": 11,
      "beatId": "b496765f-3b27-4e79-a558-0914eb2e37af",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Call to Adventure",
      "beatSlug": "heros-journey-call-to-adventure",
      "evidence": "The presentation highlights Absci's achievement as the first to design and validate novel antibodies using zero-shot generative AI.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 12,
      "from": 11,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "ccd4a0b0-a966-4e5d-9642-a95179cbdd6f",
      "evidence": "The presentation introduces Absci's achievement as the first to design and validate novel antibodies using zero-shot generative AI.",
      "position": 1,
      "objective": "Why is Absci's AI platform important?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}